this article from forbes on july 28 had a reference to market volatility by focusing on a manufacturer. It highlighted how up until that point traders were pushing the stock down. Trading at $540.56, it was down by $5.71 or 1.05% in 24 hours. P/e ratios this year and forecasted for the next few years are:74.66, 66.48, 55.86, 45.73 is that a good investment?
http://www.forbes.com/sites/dividendchannel/2015/07/28/regeneron-pharmaceuticals-becomes-11-most-shorted-nasdaq-100-component-replacing-tractor-supply/
From yahoo today it is at $582.47. With the drug approval it makes sense that investors would think it is worth more.
No comments:
Post a Comment